Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Polo-like Kinase 1 as an emerging drug target: structure, function and therapeutic implications

Published:2020-09-14 Issue:2 Volume:29 Page:168-184
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Shakeel Ilma¹^ORCID,Basheer Neha²,Hasan Gulam Mustafa³,Afzal Mohammad¹,Hassan Md. Imtaiyaz⁴^ORCID

Affiliation:

1. Department of Zoology, Aligarh Muslim University, Aligarh, India

2. Institute of Neuroimmunology, Slovak Republic Bratislava, Bratislava, Slovakia

3. Department of Biochemistry, College of Medicine, Prince Sattam Bin Abdulaziz University, Al-Kharj, Kingdom of Saudi Arabia

4. Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India

Funder

Council of Scientific and Industrial Research, Government of India

Council of Scientific and Industrial Research for financial support

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2020.1818760

Reference170 articles.

1. Multifaceted polo-like kinases: drug targets and antitargets for cancer therapy

2. Shared and separate functions of polo-like kinases and aurora kinases in cancer

3. Cell cycle regulation of the activity and subcellular localization of Plk1, a human protein kinase implicated in mitotic spindle function.

4. Polo-like Kinase Is a Cell Cycle-regulated Kinase Activated during Mitosis

5. GFP tagging reveals human Polo-like kinase 1 at the kinetochore/centromere region of mitotic chromosomes

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Progress with polo-like kinase (PLK) inhibitors: a patent review (2018–present);Expert Opinion on Therapeutic Patents;2024-07-15

2. Targeting polo‐like kinase 1 to treat kidney diseases;Cell Biochemistry and Function;2024-07

3. Targeted PLK1 suppression through RNA interference mediated by high‐fidelity Cas13d mitigates osteosarcoma progression via TGF‐β/Smad3 signalling;Journal of Cellular and Molecular Medicine;2024-05

4. The Promise of Combination Therapies with FOXM1 Inhibitors for Cancer Treatment;Cancers;2024-02-12

5. Polo-like kinase 1 as a biomarker predicts the prognosis and immunotherapy of breast invasive carcinoma patients;Oncology Research;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3